Back
Bio-Techne Quote, Financials, Valuation and Earnings
Sponsored
TECH
Sponsored
Take advantage of the biggest IPO in history
Click here to see more
Sell
38
TECH
Bio-Techne
Last Price:
78.73
Seasonality Move:
5.11%
7 Day Trial
ALL ACCESS PASS
$
7
Forget 99.987% of Stocks (Use This ONE Instead)
See how to make massive profits by abandoning 8,251 of the 8,252 publicly traded stocks!Bio-Techne Price Quote
$78.73
-0.03 (0.41%)
(Updated: September 2, 2023 at 6:23 AM ET)
Bio-Techne Key Stats
Sell
38
Bio-Techne (TECH)
is a Sell
Day range:
$78.42 - $79.97
52-week range:
$68.00 - $90.63
Dividend yield:
0.41%
P/E ratio:
44.75
P/S ratio:
11.22
P/B ratio:
6.34%
Volume:
510.8K
Avg. volume:
799.3K
1-year change:
-5.35%
Market cap:
$12.5B
Revenue:
$1.1B
EPS:
$1.76
How Much Does Bio-Techne Make?
-
How Much Are Bio-Techne's Sales Annually?
TECH Revenues are $1.1B -
How Much Profit Does Bio-Techne's Make A Year?
TECH net income is $285.3M
Is Bio-Techne Growing As A Company?
-
What Is Bio-Techne's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.05% -
What Is Bio-Techne's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.25%
Bio-Techne Stock Price Performance
-
Did Bio-Techne Stock Go Up Last Month?
Bio-Techne share price went down by -4.07% last month -
Did TECH's Share Price Rise Over The Last Year?
TECH share price fell by -5.35% over the past 1 year
What Is Bio-Techne 52-Week High & Low?
-
What Is Bio-Techne’s 52-Week High Share Price?
Bio-Techne has traded as high as $90.63 over the past 52 weeks -
What Is Bio-Techne’s 52-Week Low Share Price?
Bio-Techne has traded as low as $68.00 over the past 52 weeks
Bio-Techne Price To Free Cash Flow
-
Is Bio-Techne Stock Overvalued?
Bio-Techne is trading at a price to free cash flow ratio of 59.00 -
Is Bio-Techne Stock Undervalued?
Bio-Techne EV to Free Cash Flow ratio is 58.31 -
What Is Bio-Techne’s Price Earnings Growth Ratio?
TECH PEG ratio is 7.24 -
Is Bio-Techne Trading At A Premium To Earnings?
Bio-Techne EV to EBIT ratio is 36.02
Is It Risky To Buy Bio-Techne?
-
How Much Debt Does Bio-Techne Have?
Total long term debt quarterly is $350M -
How Much Cash Does Bio-Techne Have?
Cash and short term investments quarterly total is $204.3M -
What Is Bio-Techne’s Book Value Per Share?
Book value per share is 12.47
Is Bio-Techne Cash Flow Positive?
-
What Is TECH Cash Flow From Operations?
Cash flow from operations (TTM) is $254.4M -
What Is Bio-Techne’s Cash Flow From Financing?
Cash flow from financing (TTM) is $22.6M -
What Is Bio-Techne’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$265.6M
Bio-Techne Return On Invested Capital
-
Is Management Doing A Good Job?
TECH return on invested capital is 13.49% -
What Is Bio-Techne Return On Assets?
ROA measures how assets are converting to revenues and is 11.65% -
What Is TECH Return On Equity?
ROE is a measure of profitability and is 15.61%
Bio-Techne Earnings Date & Stock Price
-
What Is Bio-Techne's Stock Price Today?
A single share of TECH can be purchased today for 78.76 -
What Is Bio-Techne’s Stock Symbol?
Bio-Techne trades on the nasdaq under the ticker symbol: TECH -
When Is Bio-Techne’s Next Earnings Date?
The next quarterly earnings date for Bio-Techne is scheduled on November 1, 2023 -
When Is TECH's next ex-dividend date?
Bio-Techne's next ex-dividend date is August 17, 2023 -
How To Buy Bio-Techne Stock?
You can buy Bio-Techne shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bio-Techne Competitors
-
Who Are Bio-Techne's Competitors?
Below is a list of companies who compete with Bio-Techne or are related in some way:
Bio-Techne Dividend Yield
-
What Is TECH Dividend Yield?
Bio-Techne’s dividend yield currently is 0.41% -
What Is Bio-Techne’s Payout Ratio?
Bio-Techne’s payout ratio is 17.63% -
When Did Bio-Techne Last Pay A Dividend?
The latest dividend pay date is September 4, 2023 -
What Is Bio-Techne’s Dividend Per Share?
Bio-Techne pays a dividend of $0.08 per share
Bio-Techne Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 24.5% | 0.34% |
Revenue: | 4.54% | -2.26% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 100.70 |
Upside from Last Price: | 27.86% |